Nephrotoxicity pp 297-302 | Cite as

The Effect of Biliary Cannulation or Ligation on Cyclosporin A (CsA) Nephrotoxicity in The Rat

  • S. D. Heys
  • J. I. Duncan
  • P. H. Whiting


Although Cyclosporin A (CsA) has become widely accepted as the agent of choice for the control of organ allograft rejection, its attendant nephrotoxicity may still limit its clinical use (Flechner et al, 1983). This property of CsA has, to date, restricted its evaluation as an immunotherapeutic agent in areas of clinical medicine other than transplanation (eg autoimmune disorders). This nephrotoxicity is characterised in both animals and man by a reduction in glomerular filtration rate and by structural damage to the renal proximal tubules (Mihatsch et al, 1985; Blair et al, 1982; Thomson et al, 1984). The pathogenesis of CsA-induced nephrotoxicity, however remains unclear as does the identity of the toxic species, be it parent molecule and/or a metabolite (s).


Aspartate Transaminase Biliary Cannulation Hepatic Drug Metabolism Creatinine Clearance Rate Ligation Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Annesley, I., Matz, K. I Balogh, L. and Clayton, G. D., 1986, Liquid chromatographic analysis for cyclosporine with use of a microcolumn and small sample volume, Clin. Chem., 32: 1407.PubMedGoogle Scholar
  2. Augustine, J. A. and Zemaitis, M. A., 1986, The effects of cyclosporine A (CsA) on hepatic microsomal drug metabolism in the rat, Drug Metab. Dispos. 14: 73.PubMedGoogle Scholar
  3. Blair, J. T., Thomson, A. W., Whiting, P. H., Davidson, R. J. L. and Simpson, J. G., 1982, Toxicity of the immune suppressant cyclosporine A in the rat, J. Path., 135: 163.Google Scholar
  4. Cunningham, C., Burke, M. D., Wheat ley, D. N., Thomson, A. W., Simpson, J. G. and Whiting, P. H., 1985, Amelioration of cyclosporine-induced nephrotoxicity in rats by induction of hepatic drug metabolism, Biochem. Pharmac., 34: 573.CrossRefGoogle Scholar
  5. Cunningham, C., Gavin, M. P., Whiting, P. H., Burke, M. D., McIntyre, F., Thomson, A. W. and Simpson, J. G. : 1984, Serum cyclosporin levels, hepatic drug metabolism and renal tubulotoxicity, Biochem. Pharmac., 33: 2857.CrossRefGoogle Scholar
  6. Flechner, S. M., Buren, C. V., Kerman, R. H. and Kahan, B. D., 1983, The nephrotoxicity of cyclosporine in renal transplant recipients, Transplant. Proc., 15: 2689.Google Scholar
  7. Hess, A. D. and Colombani, P. M., 1986, Mechanism of action of cyclosporine: Role of calmodulin, cyclophilin, and other cyclosporine-binding proteins, Transplant. Proc., 18: 219.PubMedGoogle Scholar
  8. Kahan, B. D., Reid, M. and Newburger, J., 1983, Pharmacokinetics of cyclosporine in human renal transplantation, Transplant. Proc., 15: 446.Google Scholar
  9. Niwa, Y., Kang, T., Taniguchi, S., Miyachi, Y., and Sakane, T., 1986, Effect of cyclosporin A on the membrane associated events in human leukocytes with special reference to the similarity with dexamethasone, Biochem. Pharmac., 35: 947.CrossRefGoogle Scholar
  10. Maurer, G. T 1985: Metabolism of cyclosporine, Transplant. Proc., 17 (Suppl. 1): 19.PubMedGoogle Scholar
  11. Maurer, G., Loosli, H. R., Schreier, E., and Keller, B., 1984, Disposition of cyclosporin in several animal species and man, Drug Metab. Dispos., 12: 120.PubMedGoogle Scholar
  12. McAuley, F. T., Simpson, J. G., Thomson, A. W. and Whiting, P. H., 1987a, Cyclosporin A-induced nephrotoxicity in the rat: Relationship to increased plasma renin activity, Agents Actions, 21: 209.PubMedCrossRefGoogle Scholar
  13. McAuley, F. T., Whiting, P. H., Thomson, A. M. and Simpson, J. G., 1987b, The influence. of enalapril or spironolactone on experimental cyclosporin nephrotoxicity, Biochem. Pharmac., 36: 699.CrossRefGoogle Scholar
  14. Mihatsch, M. J., Thiel, G., Basler, V., Ryffel, B. : Landmann, J., von Overbeck, J., and Zollinger, H. U., 1985, Morphological patterns in cyclosporine-treated renal transplant patients, Transplant. Proc., 17 (Suppl. 1): 101.PubMedGoogle Scholar
  15. Moochhala, S. M. and Renton, K. M., 1986: Inhibition of hepatic microsomal drug metabolism by the immunosuppressive agent cyclosporin A, Biochem. Pharmac., 35: 1499.CrossRefGoogle Scholar
  16. Ryffel, B., Hiestand, P., Foxwell, B., Donatsch, P., Boelsterli, H. J., Maurer, G. and Mihatsch, M. J., 1986, Nephrotoxic and immunosuppressive potentials of cyclosporine metabolites in rats, Transplant. Proc., 18 (Suppl. 5): 41.PubMedGoogle Scholar
  17. Thomson, A. M., Whiting, P. H. and Simpson, J. G., 1984, Cyclosporine: immunology, toxicity and pharmacology in experimental animals, Agents Actions, 15: 306.PubMedCrossRefGoogle Scholar
  18. Whiting, P. H., Burke, M. D. and Thomson, A. W., 1986, Drug interactions with Cyclosporine: Implications from animal studies, Transplant. Proc., 18 (Suppl. 5): 56.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • S. D. Heys
    • 1
  • J. I. Duncan
    • 1
  • P. H. Whiting
    • 1
  1. 1.Department of Chemical PathologyUniversity of AberdeenAberdeenUK

Personalised recommendations